Briefing
Association of tumor-informed circulating tumor DNA dynamics with radiologic disease assessment in a single-center real-world sarcoma cohort
At a single sarcoma center, 20 patients were screened for tumor-informed ctDNA targets and 14 (70%) had a trackable target. Across 67 paired ctDNA and imaging assessments, agreement was 88.1% (Cohen's kappa=0.755). Using imaging as the reference, ctDNA had a descriptive sensitivity of 80.0% and specificity of 94.6% for progressive disease. These estimates did not account for repeated measures within patients.
- Design: Evidence level 3
- Assay: Not named in the abstract